Prot #B7931005: A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate the Efficacy And Safety Profile of PF-06651600 and PF-06700841 in Subjects With Moderate To Severe Alopecia Areata

Project: Research project

Project Details

StatusFinished
Effective start/end date4/18/17 → 4/18/20

Funding

  • INC Research, LLC (Prot #B7931005 // Prot #B7931005)
  • Pfizer Inc. (Prot #B7931005 // Prot #B7931005)